Stock listing
A2P9T4 Stock Price, News, Filings & Events — Scynexis, Inc.
Selected listing: A2P9T4 · LSX · EUR · DE
This page tracks Scynexis, Inc.'s A2P9T4:LSX listing on LSX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A2P9T4:LSX. A2P9T4:LSX is the stock-level entry point for investors researching Scynexis, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
- Ticker
- A2P9T4:LSX
- Asset type
- Stock
- Market cap
- $53.6M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- LSX
- Currency
- EUR
Scynexis, Inc. A2P9T4:LSX stock context
This page tracks Scynexis, Inc.'s A2P9T4:LSX listing on LSX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A2P9T4:LSX. A2P9T4:LSX is the stock-level entry point for investors researching Scynexis, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
Latest news from Scynexis, Inc.
SCYNEXIS to Participate in Upcoming Investor Conferences
September 1, 2026
SCYNEXIS Announces Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
August 25, 2026
SCYNEXIS Reports Second Quarter 2026 Financial Results and Provides Corporate Update
August 10, 2026
SCYNEXIS Initiates Phase 1 Study of SCY-770, a Novel AMPK Activator for the Treatment of Autosomal Dominant Polycystic Kidney Disease (AD...
June 30, 2026
SCYNEXIS Announces One-for-Eight Reverse Stock Split
May 22, 2026
Scynexis, Inc. earnings calls
SCYNEXIS, Inc. (SCYX) Q3 2022 Earnings Call
November 9, 2022 · Replay with transcript and chapters
SCYNEXIS, Inc. (SCYX) Q2 2022 Earnings Call
August 15, 2022 · Replay with transcript and chapters
SCYNEXIS, Inc. (SCYX) Q1 2022 Earnings Call
May 12, 2022 · Replay with transcript and chapters
SCYNEXIS, Inc. (SCYX) Q3 2021 Earnings Call
November 10, 2021 · Replay with transcript and chapters
Research Scynexis, Inc.
Scynexis, Inc. investor report
Review AI stock analysis and investor report context for A2P9T4:LSX.
Scynexis, Inc. company profile
View the public company page for Scynexis, Inc. on 6ix.
Scynexis, Inc. news
Read company news and market updates connected to Scynexis, Inc..
Scynexis, Inc. investor events
Find investor webinars, events, and replay context for Scynexis, Inc..
Alternate listings
SCYX:NASDAQ
US · USD
Alternate listing for Scynexis, Inc.; the primary context on this page is A2P9T4:LSX.
135A:GETTEX
DE · EUR
Alternate listing for Scynexis, Inc.; the primary context on this page is A2P9T4:LSX.
A2P9T4:LS
DE · EUR
Alternate listing for Scynexis, Inc.; the primary context on this page is A2P9T4:LSX.
0L49:LSE
GB · USD
Alternate listing for Scynexis, Inc.; the primary context on this page is A2P9T4:LSX.
SCYX:BOATS
US · USD
Alternate listing for Scynexis, Inc.; the primary context on this page is A2P9T4:LSX.
135A:FWB
DE · EUR
Alternate listing for Scynexis, Inc.; the primary context on this page is A2P9T4:LSX.
135A:DUS
DE · EUR
Alternate listing for Scynexis, Inc.; the primary context on this page is A2P9T4:LSX.
135A:MUN
DE · EUR
Alternate listing for Scynexis, Inc.; the primary context on this page is A2P9T4:LSX.
135A:SWB
DE · EUR
Alternate listing for Scynexis, Inc.; the primary context on this page is A2P9T4:LSX.
135A:TRADEGATE
DE · EUR
Alternate listing for Scynexis, Inc.; the primary context on this page is A2P9T4:LSX.